Monomeric CRP is Elevated in Patients with COPD Compared to Non-COPD Control Persons

Revathy Munuswamy1 Faculty of Medicine and Life Sciences, Biomedical Research Institute BIOMED, Hasselt University, Hasselt, BelgiumView further author information

Jana De Brandt2 Faculty of Rehabilitation Sciences, Rehabilitation Research Center REVAL, Biomedical Research Institute BIOMED, Hasselt University, Hasselt, Belgium

https://orcid.org/0000-0003-3463-1911 View further author information

Chris Burtin2 Faculty of Rehabilitation Sciences, Rehabilitation Research Center REVAL, Biomedical Research Institute BIOMED, Hasselt University, Hasselt, BelgiumView further author information

Wim Derave3 Department of Movement and Sports Sciences, Ghent University, Ghent, BelgiumView further author information

Joseph Aumann4 Department of Pneumology, Jessa Hospital, Hasselt, BelgiumView further author information

Martijn A Spruit5 Department of Research and Development, CIRO, Horn, the Netherlands;6 Department of Respiratory Medicine, Maastricht University Medical Centre, Faculty of Health, Medicine and Life Sciences, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht, the Netherlands

https://orcid.org/0000-0003-3822-7430 View further author information

Luc Michiels1 Faculty of Medicine and Life Sciences, Biomedical Research Institute BIOMED, Hasselt University, Hasselt, BelgiumCorrespondence[email protected]
View further author information

show all

References

Agustí A, Edwards LD, Rennard SI, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012;7(5):e37483. doi:10.1371/journal.pone.0037483
PubMed Web of Science ®Google Scholar
Trial J, Potempa LA, Entman ML. The role of C-reactive protein in innate and acquired inflammation: new perspectives. Inflamm Cell Signal. 2016;3(2).
PubMedGoogle Scholar
Hurst JR, Donaldson GC, Perera WR, et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;174(8):867–874. doi:10.1164/rccm.200604-506OC
PubMed Web of Science ®Google Scholar
Leuzzi G, Galeone C, Taverna F, et al. C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis. Eur Respir Rev. 2017;26(143):160070. doi:10.1183/16000617.0070-2016
PubMed Web of Science ®Google Scholar
de la Torre R, Peña E, Vilahur G, et al. Monomerization of C-reactive protein requires glycoprotein IIb-IIIa activation: pentraxins and platelet deposition. J Thromb Haemost. 2013;11(11):2048–2058. doi:10.1111/jth.12415
PubMed Web of Science ®Google Scholar
Aksu F, Capan N, Aksu K, et al. C-reactive protein levels are raised in stable chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure. J Thorac Dis. 2013;5(4):414–421.
PubMed Web of Science ®Google Scholar
Perng D-W, Tao C-W, Su K-C, et al. Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD. Eur Respir J. 2009;33(4):778–784. doi:10.1183/09031936.00115308
PubMed Web of Science ®Google Scholar

Monomeric CRP is Elevated in Patients with COPD Compared to Non-COPD Control Persons

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Monomeric CRP is Elevated in Patients with COPD Compared to Non-COPD Control Persons

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date